PIPELINE
Report
- Report Number
- 2029214-2020-00245
- Event Type
- Death
- Date Received
- March 17, 2020
- Date of Event
- October 1, 2015
- Report Date
- March 17, 2020
- Manufacturer
- MICRO THERAPEUTICS, INC. DBA EV3
- Product Code
- OUT
- PMA / PMN Number
- P100018.S004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER
Narratives
SEE RELATED REGULATORY REPORT 2029214-2020-00244. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
LV X, JIANG C, WU Z, JIANG W, WANG G. COMPLEX CEREBRAL ANEURYSMS: INTRA-LUMINAL RECONSTRUCTION USING PIPELINE FLOW-DIVERTING STENT AND THE OBLITERATION MECHANISM. THE NEURORADIOLOGY JOURNAL. DECEMBER 2019:1971400919894879. DOI:10.1177/1971400919894879. MEDTRONIC RECEIVED A REPORT THROUGH LITERATURE TO DOCUMENT THE CLINICAL AND ANGIOGRAPHIC OUTCOMES IN 80 PATIENTS WHO WERE TREATED WITH THE PIPELINE FLOW-DIVERTING STENT. FORTY-FIVE PATIENTS WERE WOMEN AND 35 WERE MEN, WITH A MEAN AGE OF 52 YEARS. THE STUDY TOOK PLACE BETWEEN OCTOBER 2015 AND OCTOBER 2019, 80 PATIENTS WITH 90 COMPLEX BLOOD BLISTER¿LIKE, AND RECURRENT SIDE-WALL CEREBRAL ANEURYSMS TREATED WITH THE PIPELINE WERE REVIEWED. FORTY-ONE ANEURYSMS WERE LARGE OR GIANT, 41 WERE SMALL, FOUR WERE RECURRENT SIDE-WALL ANEURYSMS, AND FOUR WERE BLOOD BLISTER¿LIKE ANEURYSMS. IN SEVEN PATIENTS, A SECOND PFS WAS NECESSARY TO COVER THE ANEURYSM NECK. AMONG THEM, COILS WERE PLACED IN ADDITION TO THE PFS IN 31 ANEURYSMS. 82 OF 83 ANEURYSMS WERE OCCLUDED FOR A TOTAL OCCLUSION RATE OF 98.8% THERE WAS NO PATIENT RELATED MORBIDITY. MORTALITY OCCURRED IN ONE PATIENT DUE TO THROMBOLYSIS FROM THROMBUS FORMATION IN THE LEFT ICA, RESULTING IN AN IPSILATERAL REMOTE INTRAPARENCHYMAL HEMATOMA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 307351 | PIPELINE | INTRACRANIAL ANEURYSM FLOW DIVERTER | OUT | MICRO THERAPEUTICS, INC. DBA EV3 | NV UNK PIPELINE | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | Death |